| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.07B | +7.9% |
| Gross Profit | $515.0M | +11.5% |
| R&D Expense | $14.0M | +16.7% |
| SG&A Expense | $296.0M | +7.2% |
| Operating Income | $219.0M | +17.7% |
| Interest Expense | $167.0M | +5.7% |
| Pre-tax Income | $73.0M | +49.0% |
| Income Tax | $127.0M | -65.0% |
| Net Income | -$48.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.0M | -44.7% |
| Accounts Receivable | $266.0M | -8.3% |
| Inventory | $1.55B | +9.1% |
| Current Assets | $2.15B | +0.9% |
| Total Assets | $6.04B | -1.6% |
| Current Liabilities | $874.0M | +16.1% |
| Long-term Debt | $2.76B | -1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $300.0M | +63.0% |
| Investing Cash Flow | -$343.0M | -34.5% |
| Financing Cash Flow | -$71.0M | -140.3% |
| +84.8% |
| EPS (Basic) | -$0.31 | +84.7% |
| EPS (Diluted) | -$0.31 | +84.7% |
| Total Liabilities |
| $4.25B |
| +2.2% |
| Stockholders' Equity | $1.76B | -9.0% |